What is NDC 72516-024?

72516-024 is the product NDC for Papaverine Hydrochloride, Papaverine hydrochloride 30 mg/mL injection, solution, listed with the FDA by Oryza Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Oryza Pharmaceuticals Inc., NDC labeler code 72516. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Papaverine Hydrochloride?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Papaverine Hydrochloride NDC 72516-024

NDC codes

FDA NDC Directory

Product NDC (as listed)72516-024Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72516-0024Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72516-024-10	7251600241072516002410	10 VIAL in 1 CARTON (72516-024-10) / 2 mL in 1 VIALMarketed from Feb 1, 2021
72516-024-25	7251600242572516002425	25 VIAL in 1 CARTON (72516-024-25) / 2 mL in 1 VIALMarketed from Feb 1, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Papaverine Hydrochloride
Generic name (nonproprietary): papaverine hydrochloride
Active ingredients: Papaverine hydrochloride — 30 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Oryza Pharmaceuticals Inc.NDC labeler code 72516
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Feb 1, 2021
Listing expires: Dec 31, 2026
Identifiers: Product ID 72516-024_2b4bd8c6-2b93-d435-e063-6394a90ae742SPL ID 2b4bd8c6-2b93-d435-e063-6394a90ae742SPL set ID 5ba6e650-a5b5-4381-a62a-b7a6df73e8e6RxCUI 1789947UNII 23473EC6BQ

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472516002410 followed by a unit qualifier and the quantity

Package 72516-0024-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 9, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Papaverine is recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states; and visceral spasm, as in ureteral, biliary, or gastrointestinal colic.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72516-024

What is NDC 72516-024?: 72516-024 is the product NDC for Papaverine Hydrochloride, Papaverine hydrochloride 30 mg/mL injection, solution, listed with the FDA by Oryza Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Papaverine Hydrochloride.
What is the active ingredient?: Papaverine hydrochloride.
Who is the labeler?: Oryza Pharmaceuticals Inc., NDC labeler code 72516. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Papaverine Hydrochloride?: 3 other product NDCs are listed under this name. See all Papaverine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Papaverine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Papaverine Hydrochloride	Papaverine hydrochloride 30 mg/mL	Injection, SolutionIntramuscular, Intravenous, Parenteral	BPI Labs LLC	54288-142	54288-0142-1054288-0142-25
Papaverine Hydrochloride	Papaverine hydrochloride 30 mg/mL	InjectionIntramuscular, Intravenous	Nexus Pharmaceuticals, LLC	14789-121	14789-0121-05
Papaverine Hydrochloride	Papaverine hydrochloride 30 mg/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-4002	00517-4002-25